FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

Tempest Therapeutics, Inc.: net_income

One fact, its scope and the complete path back to the official record.

Period: 2023-01-01 – 2023-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/d9b6987c-2e5e-43fd-8c64-25c4292c4f4a

Reported value

$-29.491M{"amount": -29491000, "concept": "us-gaap:NetIncomeLoss", "currency": "USD"}
Entity
Tempest Therapeutics, Inc.
Metric
net_income
Period
2023-01-01 – 2023-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0000950170-24-033555 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T15:40:30.925694+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001544227/net-income/2023-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.